A single immunization with a recombinant canine adenovirus type 2 expressing the seoul virus Gn glycoprotein confers protective immunity against seoul virus in mice

Vaccine

Volumn 27, Issue 38, 2009, Pages 5247-5251

  Yuan, Zi Guo ^a,b   Li, Xiu Ming ^c   Mahmmod, Yasser Saad ^d   Wang, Xiao Hu ^b   Xu, Hui Juan ^e   Zhang, Xiu Xiang ^a,f  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c HEILONGJIANG AUGUST FIRST LAND RECLAMATION UNIVERSITY   (China)

^d Zagazig University   (Egypt)

^e GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^f Laboratory of Molecular Biology   (China)

Author keywords

Canine adenovirus type 2; Gn; Immunity; Mice; Seoul virus

Indexed keywords

ANTIBODY; GLYCOPROTEIN; INACTIVATED VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT CANINE ADENOVIRUS TYPE 2 VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADENOVIRUS 2; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEOUL VIRUS; SINGLE DRUG DOSE; VIRUS HEMORRHAGIC FEVER; VIRUS IMMUNITY; VIRUS INFECTIVITY; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ADENOVIRUSES, CANINE; ANIMALS; ANTIBODIES, VIRAL; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CRICETINAE; DOGS; FEMALE; HEMAGGLUTINATION TESTS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; SEOUL VIRUS; VERO CELLS; VIRAL VACCINES;

EID: 67749089314     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.062     Document Type: Article

References (38)

1. Kariwa H., Yoshimatsu K., and Arikawa J. Hantavirus infection in East Asia. Comp Immunol Microbiol Infect Dis 30 5-6 (2007) 341-356
2. Schmaljohn C.S. Molecular biology of hantaviruses. In: Elliott R.M. (Ed). The bunyaviridae (1996), Plenum Press, New York 63-90
3. Arikawa J., Schmaljohn A.L., Dalrymple J.M., and Schmaljohn C.S. Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J Gen Virol 70 3 (1989) 615-624
4. Dantas J.R., Okuno Y., Asada H., Tamura M., Takahashi M., Tanishita O., et al. Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. Virology 151 2 (1986) 379-384
5. Zhang X.K., Takashima I., and Hashimoto N. Characteristics of passive immunity against hantavirus infection in rats. Arch Virol 105 3-4 (1989) 235-246
6. Lee H.W., Ahn C.N., Song J.W., Baek L.J., Seo T.J., and Park S.C. Field trial of an inactivated vaccine against hemorrhagic fever with renal syndrome in humans. Arch Virol 1 Suppl. (1990) 35-47
7. Song G., Huang Y.C., Hang C.S., Hao F.Y., Li D.X., Zheng X.L., et al. Preliminary human trial of inactivated golden hamster kidney cell (GHKC) vaccine against haemorrhagic fever with renal syndrome (HFRS). Vaccine 10 4 (1992) 214-216
8. Schmaljohn C.S., Arikawa J., Dalrymple J.M., and Schmaljohn A.L. Expression of the envelope glycoprotein of Hantaan virus with vaccinia and baculovirus recombinants. In: Kolakofsky D., and Mahy B.W.J. (Eds). Genetics and pathgenicity of negative strand viruses (1989), Elsevier, Amsterdam/New York 58-66
9. Schmaljohn C.S., Chu Y.K., Schmaljohn A.L., and Dalrymple J.M. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol 64 7 (1990) 3162-3170
10. Yoshimatsu K., Yoo Y.C., Yoshida R., Ishihara C., Azuma I., and Arikawa J. Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins. Arch Virol 130 3-4 (1993) 365-376
11. Carmichael L.E. Canine viral vaccines at a turning point-a personal perspective. Adv Vet Med 41 (1999) 289-307
12. Hu R., Zhang S., Fooks A.R., Yuan H., Liu Y., Li H., et al. Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. Microbes Infect 8 4 (2006) 1090-1097
13. Hu R.L., Liu Y., Zhang S.F., Zhang F., and Fooks A.R. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Vaccine 25 29 (2007) 5301-5307
14. Randrianarison-Jewtoukoff V., and Perricaudet M. Recombinant adenoviruses as vaccines. Biologicals 23 2 (1995) 145-157
15. Xia X.Z., Fang Q.S., and Huang G. Isolation and identification of a canine adenovirus avirulent strain. Chin J Vet Med 34 3 (2000) 1-4 [in Chinese]
16. Yuan Z.G., Zhang X.X., Zhang S.F., Liu Y., Gao S.Y., Zhang F., et al. Development of recombinant canine adenovirus type-2 expressing the Gn glycoprotein of Seoul virus. Biologicals 36 3 (2007) 1-6
17. Rosenbaum M.J., Edwards E.A., and Sullivan E.J. Micromethods for respiratory virus sero-epidemiology. Health Lab Sci 7 1 (1970) 42-53
18. Tham K.M., Horner G.W., and Hunter R. Isolation and identification of canine adenovirus type-2 from the upper respiratory tract of a dog. NZ Vet J 46 3 (1998) 102-105
19. Yin Z., and Liu J.H. Animal virology. 2nd ed. (1997), Science Press, Beijing [in Chinese]
20. Xiao S., Chen H., Fang L., Liu C., Zhang H., Jiang Y., et al. Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice. Vaccine 22 3-4 (2004) 345-351
21. Hong W., Xiao S., Zhou R., Fang L., He Q., Wu B., et al. Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets. Vaccine 20 7-8 (2002) 1205-1214
22. Bounous D.I., Campagnoli R.P., and Brown J. Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian Dis 36 4 (1992) 1022-1027
23. Araki K., Yoshimatsu K., Ogino M., Ebihara H., Lundkvist A., Kariwa H., et al. Truncated hantavirus nucleocapsid proteins for serotyping Hantaan, Seoul, and Dobrava hantavirus infections. J Clin Microbiol 39 7 (2001) 2397-2404
24. Asada H., Balachandra K., Tamura M., Kondo K., and Yamanishi K. Cross-reactive immunity among different serotypes of virus causing haemorrhagic fever with renal syndrome. J Gen Virol 70 Pt4 (1989) 819-825
25. Wichmann D., Grone H.J., Frese M., Pavlovic J., Anheier B., Haller O., et al. Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice. J Virol 76 17 (2002) 8890-8899
26. Yamanishi K., Tanishita O., Tamura M., Asada H., Kondo K., Takagi M., et al. Development of inactivated vaccine against virus causing haemorrhagic fever with renal syndrome. Vaccine 6 3 (1988) 278-282
27. Arikawa J., Schmaljohn A.L., Dalrymple J.M., and Schmaljohn C.S. Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J Gen Virol 70 Pt3 (1989) 615-624
28. Arikawa J., Yao J.S., Yoshimatsu K., Takashima I., and Hashimoto N. Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies. Arch Virol 126 1-4 (1992) 271-281
29. Dantas Jr. J.R., Okuno Y., Asada H., Tamura M., Takahashi M., Tanishita O., et al. Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. Virology 151 2 (1986) 379-384
30. Schmaljohn C.S. In: Elliott R.M. (Ed). Molecular biology of Hantaviruses: the bunyaviridae (1996), Plenum Press, New York 63-90
31. Chu Y.K., Jennings G.B., and Schmaljohn C.S. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. J Virol 69 10 (1995) 6417-6423
32. Pensiero M.N., Jennings G.B., Schmaljohn C.S., and Hay J. Expression of the Hantaan virus M genome segment by using a vaccinia virus recombinant. J Virol 62 3 (1988) 696-702
33. Schmaljohn C.S., Hasty S.E., and Dalrymple J.M. Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome. Vaccine 10 1 (1992) 10-13
34. Xu X., Ruo S.L., McCormick J.B., and Fisher-Hoch S.P. Immunity to Hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins. Am J Trop Med Hyg 47 4 (1992) 397-404
35. Langeveld J.P., Casal J.I., Cortes E., van de Wetering G., Boshuizen R.S., Schaaper W.M., et al. Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine 12 15 (1994) 1473-1480
36. Christensen J., Alexandersen S., Bloch B., Aasted B., and Uttenthal A. Production of mink enteritis parvovirus empty capsids by expression in a baculovirus vector system: a recombinant vaccine for mink enteritis parvovirus in mink. J Gen Virol 75 1 (1994) 149-155
37. Schmidt N.J., Lennette E.H., and King C.J. Neutralizing, hemagglutination-inhibiting and group complement fixing antibody responses in human adenovirus infections. J Immunol 97 (1966) 64-74
38. Souza A.P., Haut L., Reyes-Sandoval A., and Pinto A.R. Recombinant viruses as vaccines against viral diseases. Braz J Med Biol Res 38 4 (2005) 509-522